Fertility preservation in cancer patients

被引:0
作者
Popovici, R. [1 ]
von Wolff, M. [2 ]
Strowitzki, T. [3 ]
机构
[1] Tech Univ Munich, Frauenklin & Poliklin, D-81675 Munich, Germany
[2] Univ Frauenklin, Inselspital, Abt Gynakol Endokrinol & Reprod Med, Bern, Switzerland
[3] Univ Heidelberg, Abt Gynakol Endokrinol & Fertilitatsstorungen, D-6900 Heidelberg, Germany
来源
ONKOLOGE | 2010年 / 16卷 / 04期
关键词
Fertility; Desire to have children; Ovary; Oocytes; CRYOPRESERVED OVARIAN TISSUE; FEMALE-PATIENTS; HUMAN OOCYTE; CHEMOTHERAPY; TRANSPLANTATION; PREGNANCY; RADIATION; SURVIVORS;
D O I
10.1007/s00761-010-1834-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survival rates of female cancer patients are Improving steadily Clinicians are increasingly confronted with the long-term effects of chemotherapy and radiotherapy on the fertility of young women. Premature ovarian failure in women who wish to become pregnant is devastating both for the patient and her partner. In the case of predictable loss of gonadal function due to a planned cancer treatment fertility preservation options should be offered to the patient. Current methods of fertility preservation include conventional reproductive techniques as well as GnRH analogue treatment, cryopreservation of oocytes and cryopreservation of ovarian tissue Most of these techniques are still experimental and should only be decided after individual and patient-specific informed consent as well as interdisciplinary counselling
引用
收藏
页码:423 / 428
页数:6
相关论文
共 23 条
[1]   LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST INHIBITS CYCLOPHOSPHAMIDE-INDUCED OVARIAN FOLLICULAR DEPLETION IN RHESUS-MONKEYS [J].
ATAYA, K ;
RAO, LV ;
LAWRENCE, E ;
KIMMEL, R .
BIOLOGY OF REPRODUCTION, 1995, 52 (02) :365-372
[2]   RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study (Retracted article. See vol. 120, pg. 395, 2023) [J].
Badawy, Ahmed ;
Elnashar, Aboubakr ;
El-Ashry, Mohamed ;
Shahat, May .
FERTILITY AND STERILITY, 2009, 91 (03) :694-697
[3]   GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data [J].
Beck-Fruchter, R. ;
Weiss, A. ;
Shalev, E. .
HUMAN REPRODUCTION UPDATE, 2008, 14 (06) :553-561
[4]   GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy [J].
Blumenfeld, Zeev ;
von Wolff, Michael .
HUMAN REPRODUCTION UPDATE, 2008, 14 (06) :543-552
[5]   Evidence-based clinical outcome of oocyte slow cooling [J].
Borini, A. ;
Bianchi, V. ;
Bonu, M. A. ;
Sciajno, R. ;
Sereni, E. ;
Cattoli, M. ;
Mazzone, S. ;
Trevisi, M. R. ;
Iadarola, I. ;
Distratis, V. ;
Nalon, M. ;
Coticchio, G. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (02) :175-181
[6]   PREGNANCY AFTER HUMAN OOCYTE CRYOPRESERVATION [J].
CHEN, C .
LANCET, 1986, 1 (8486) :884-886
[7]   Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: Case report [J].
Demeestere, Isabelle ;
Simon, Philippe ;
Buxant, Frederic ;
Robin, Valerie ;
Fernandez, Sergio Aguilar ;
Centner, Julie ;
Delbaere, Anne ;
Englert, Yvon .
HUMAN REPRODUCTION, 2006, 21 (08) :2010-2014
[8]   Livebirth after orthotopic transplantation of cryopreserved ovarian tissue [J].
Donnez, J ;
Dolmans, MM ;
Demylle, D ;
Jadoul, P ;
Pirard, C ;
Squifflet, J ;
Martinez-Madrid, B ;
Van Langendonckt, A .
LANCET, 2004, 364 (9443) :1405-1410
[9]  
Hovatta O, 1996, HUM REPROD, V11, P1268
[10]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96